Natale S. Ricciardi
Known title: DirectorCIK: 0001107158
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Prestige Consumer Healthcare Reports Q1 2027 Earnings. Prestige Consumer Healthcare released the transcript of its Q1 2027 earnings call. The company discussed its quarterly results and outlook, providing detailed guidance on revenue, earnings, and future plans. The release offers investors a clearer view of the company's performance and strategy.
Transaction History
| RPID | ▲ Buy | Option Exercise | 842 | $632 | 2/27/2026 | View on chart |
| RPID | ▲ Buy | Grant | 14,300 | $0 | 5/22/2025 | View on chart |
| RPID | ▲ Buy | Grant | 14,300 | $0 | 5/23/2024 | View on chart |
| PBH | ▲ Buy | Grant | 2,295 | $0 | 8/1/2023 | View on chart |
| PBH | ▲ Buy | Grant | 2,495 | $0 | 8/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
RPID Presents at Small-Cap Virtual Conference
Rapid Micro Biosystems presented at a small‑cap virtual conference, sharing updates on its product pipeline and business strategy. The event offered investors a chance to hear directly from management about recent progress and future plans. The presentation follows the company’s recent trading activity, with an RSI of 31.3 and support near $1.66.
RPID Presents at Small-Cap Virtual Conference. Rapid Micro Biosystems presented at a small‑cap virtual conference, sharing updates on its product pipeline and business strategy. The event offered investors a chance to hear directly from management about recent progress and future plans. The presentation follows the company’s recent trading activity, with an RSI of 31.3 and support near $1.66.